Skip to Main Content

March 17, 2023   
Health Law Weekly

Novo Nordisk, Sanofi Join Elly Lily in Cutting Insulin Prices

  • March 17, 2023

Drug manufacturers Novo Nordisk and Sanofi both announced this week plans to cut U.S. list prices for their insulin products amid ongoing pressure from the federal government and the public to lower costs for consumers.  


You must be logged in to access this content.